Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SCHOTT Pharma Expands Vial Production in Lebanon, PA | Contract Pharma

What are you searching for?

Sign in
Breaking News

SCHOTT Pharma Expands Vial Production in Lebanon, PA

Inaugurates new production lines for both standard and sterile ready-to-use (RTU) glass vials.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Image Credit: SCHOTT Pharma, Nils Hendrik.

SCHOTT Pharma has inaugurated new production lines for both standard and sterile ready-to-use (RTU) glass vials designed to store a wide range of drugs—from biologics and other complex injectable therapies to vaccines and emergency room medications.

The new capabilities feature new technology for efficient manufacturing and optimized output. The over $60 million investment was largely funded by the Biomedical Advanced Research and Development Authority (BARDA) to strengthen the resilience of the U.S. pharmaceutical supply chain and ensure reliable domestic production of critical primary packaging. The expansion significantly increases the site’s annual production capacity for core vials, while more than tripling local capacity for high-value solutions.

“The expansion contributes to SCHOTT Pharma’s long-term global growth strategy, with a strong local-for-local presence in the U.S. and scaled manufacturing capacity for high-value solutions that address key trends in the pharmaceutical industry, such as biologic medications and novel drug formulations,” says Christian Mias, CEO of SCHOTT Pharma.

In addition to installing a significant number of new high-end converting lines for core borosilicate glass vials, the expansion in Lebanon included major infrastructure modernization, line upgrades, and new technology to increase the capacity for high-value solutions. These include the RTU vial platform adaptiQ and EVERIC pure vials.

The Lebanon, PA site is one of only two SCHOTT Pharma locations worldwide capable of manufacturing EVERIC pure vials, which feature high chemical durability, a homogeneous inner surface, and tight dimensional tolerances to ensure high drug stability throughout its shelf life. It is also the only SCHOTT Pharma site producing adaptiQ pre‑washed, pre‑sterilized RTU vials, supplying these high performance containers across the U.S. and globally.

More SCHOTT News

Earlier this year, SCHOTT Pharma launched a pre-validated ISO-standardized polymer cartridge through its collaboration with SHL Medical.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics